Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
OcuTerra Therapeutics
company
About
OcuTerra Therapeutics is developing novel eye drop designed to treat diabetic eye disease.
- Boston,Massachusetts,United States
- 11 - 50
- https://www.ocuterratx.com/
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $35M
- Industries
- Biotechnology,Therapeutics
- Founded date
- Jan 1, 2011
- Number Of Employee
- 11 - 50
- Operating Status
- Active
OcuTerra Therapeutics, Inc. is developing innovative drugs for ophthalmic diseases for which the current standard of care does not prevent or control the progression of the disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$35M
OcuTerra Therapeutics has raised a total of
$35M
in funding over 2 rounds. Their latest funding was raised on
Nov 9, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 9, 2021 | Series B | $35M | — | — | — | Detail |
| Jun 8, 2021 | Series B | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
OcuTerra Therapeutics is funded by 1 investors.
Robin Hood Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Robin Hood Ventures
|
— | Series B |
Employee Profiles
Number of Employee Profiles
3
OcuTerra Therapeutics has 3 current employee profiles, including
Executive Kerrie Brady
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
